P27-25404-65258
1 vaccination
6 coded responses
13 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 200 / DC
- Registered
- 2022-06-23
- Relationship
- Child or adolescent in my care
- Guardian
- ZZV-82580-73210
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-22
Dose 1 — Moderna
-
2022-06-23
Registered in v-safe
-
2022-06-23
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-06-25
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-06-26
-
2022-06-28
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Decreased appetite — Feeling: Fair · Loss of appetiteFree text: Linden is having trouble eating but it seems more related to starting daycare than her vaccine.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-01
- 2022-07-06
- 2022-07-13
- 2022-07-22
-
2022-07-27
Survey response — day 35, dose 1, under 3MedDRA: Cough, Pyrexia, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Fever, cough, congestion, runny nose.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-05
Survey response — day 42, dose 1, under 3MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Fever, cough, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-08-05
Report sent to call center — day 42, dose 1, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-08-08
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-22
Survey response — 3 months, dose 1, under 3MedDRA: Nasopharyngitis, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: (b)(6) had a cold with fever for a couple days.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-21
Survey response — 6 months, dose 1, under 3MedDRA: Cough, Dermatitis diaper, Pyrexia, Respiratory syncytial virus infection, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Very serious diaper rash issues, requiring prescription ointments. RSV with fever, cough, runny nose, etc. But no breathing issues.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-21
Report sent to call center — 6 months, dose 1, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-22
-
2023-06-22
Survey response — 12 months, dose 1, under 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Moderna | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Linden is having trouble eating but it seems more related to starting daycare than her vaccine.
Release 12 (Under 3) — day 35, dose 1, under 3
Symptoms: Fever, cough, congestion, runny nose.
Release 12 (Under 3) — day 42, dose 1, under 3
Symptoms: Fever, cough, runny nose
Release 12 (Under 3) — 3 months, dose 1, under 3
Release 12 (Under 3) — 6 months, dose 1, under 3
Symptoms: Very serious diaper rash issues, requiring prescription ointments. RSV with fever, cough, runny nose, etc. But no breathing issues.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dermatitis diaper | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release